References
- Barak, S., Rubino, A., Grguric, J., Ghenev, E., Branski, D., Olah, E., & EPA/UNEPSA, Committee. (2010). The future of primary paediatric care in Europe: Reflections and report of the EPA/UNEPSA committee. Acta Paediatrica, 99(1), 13–18. doi:10.1111/j.1651-2227.2009.01546.x
- CDC. (1992). 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults (MMWR, 41). Atlanta, GA: US Department of Health and Human Services.
- Coordinamento Nazionale Associazioni Malati Cronici [National Coordination of Chronic Patients' Associations]. (2011). Rapporto nazionale sulle malattie croniche rare: l'etá pediatrica [National Report on rare chronic diseases: the pediatric age]. (Research Report No. X). Retrieved from: http://www.lila.it/archivio_doc_pss.htm
- De Martino, M., Tovo, P. A., Balducci, M., Galli, L., Gabiano, C., Rezza, G., & Pezzotti, P. (2000). Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian register for HIV infection in children and the Italian national AIDS registry. JAMA: The Journal of the American Medical Association, 284, 190–197. doi:10.1001/jama.284.2.190
- Floridia, M., Massella, M., Bucciardini, R., Peducci, C. A., Rossi, L., Tomino, C., … Vella, S. (2000). Hospitalizations and costs of treatment for protease inhibitors-based regimens in patients with very advanced HIV-infection (CD4 < 50 per mm3). HIV Clinical Trials, 1, 9–16. doi:10.1310/6ULM-XYB7-H4XP-BHFJ
- Garattini, L., Tediosi, F., Di Cintio, E., Yin, D., Parazzini, F., … Gruppo di Studio ARCA. (2001). Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy. AIDS Care, 13, 733–741. doi:10.1080/09540120120076896
- Garattini, L., Tediosi, F., Ghislandi, S., Orzella, L., … Rossi, C. (2000). How do Italian pharmacoeconomists evaluate indirect costs? Value in Health, 3, 270–276. doi:10.1046/j.1524-4733.2000.34004.x
- Gebo, K. A., Chaisson, R. E., Folkemer, J. G., Bartlett, J. G., … Moore, R. D. (1999). Costs of HIV medical care in the era of highly active antiretroviral therapy. AIDS, 13, 963–969. doi:10.1097/00002030-199905280-00013
- HIV Paediatric Prognostic Markers Collaborative Study. (2006). Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children. AIDS, 20, 1289–1294. doi:10.1097/01.aids.0000232237.20792.68
- HIV Paediatric Prognostic Markers Collaborative Study Group. (2003). Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: Estimates according to CD4 percent, viral load, and age. The Lancet, 362, 1605–1611. doi:10.1016/S0140-6736(03)14793-9
- Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., d'Arminio Monforte, A., Lundgren, J. D. (2003). Decline in the AIDS and death rates in the EuroSIDA study: An observational study. The Lancet, 362, 22–29. doi:10.1016/S0140-6736(03)13802-0
- Mouton, Y., Alfandari, S., Valette, M., Certier, F., Dellamonica, P., Humbert, G., Portier, H. (1997). Impact of protease inhibitors on AIDS-defining events and hospitalization in 10 French AIDS centers. Fédération National des Centres de Lutte contre le SIDA. AIDS, 11, F101–F105. doi:10.1097/00002030-199712000-00003
- Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., … Holmberg, S. D., … the HIV Study Outpatient Investigators. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338, 853–860. doi:10.1056/NEJM199803263381301
- PENTA Steering Committee. (2009). PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. HIV Medicine, 10, 591–613. doi:10.1111/j.1468-1293.2009.00759.x
- Sabbatani, S., … Cesari, R. (2002). Cost assessment of antiretroviral drugs used in the treatment of patients with HIV infection. Clinical Drug Investigation, 22, 253–262. doi:10.2165/00044011-200222040-00005
- Taroni, F. (1996). DRG/ROD e nuovo sistema di finanziamento degli ospedali [DRGs and the new hospital funding system], Rome: il Pensiero Scientifico Editore.
- Torres, R. A., … Barr, M. (1997). Impact of combination therapy for HIV infection on patient census. New England Journal of Medicine, 336, 1531–1532. doi:10.1056/NEJM199705223362118
- Tramarin, A., Postma, J., Gerzeli, S., Campostrini, S., Starace, F. … Palladio Study Group. (2004). The clinical and economic efficacy of HAART: A shift from inpatient medical to outpatient pharmaceutical care for HIV/AIDS patients in Northeastern Italy. AIDS Care, 16, 213–218. doi:10.1080/09540120410001641057
- Viani, R. M., Araneta, M. R. G., Deville, J. G., … Spector, S. A. (2004). Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy. Clinical Infectious Diseases, 39, 725–731. doi:10.1086/423178
- Wilson, L. S., Basu, R., Christenson, M., Hensic, L., Paoli, C.Outpatient consulta, Wara, D., & Moskowitz, J. T. (2010). Pediatric HIV costs across three treatment eras from 1986 to 2007. Pediatrics, 126, e541–e549. doi:10.1542/peds.2009-3485
![Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.]({"type":"image" , "src" : "/sda/112443/Skyscraper-socialsciences.png"})